Researchers detected high levels of SERPINB3 expression in primary liver tumors but not in normal liver tissue and showed a significant correlation with transforming growth factor-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognoses. Here, SERPINB3 is linked to hepatocellular carcinoma.